155 related articles for article (PubMed ID: 30547303)
1. Undiagnosed cardiac deficits in non-small cell carcinoma patients in the candidate population for anti-cachexia clinical trials.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Chu Q; Baracos VE
Support Care Cancer; 2019 Apr; 27(4):1551-1561. PubMed ID: 30547303
[TBL] [Abstract][Full Text] [Related]
2. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.
Miura S; Naito T; Mitsunaga S; Omae K; Mori K; Inano T; Yamaguchi T; Tatematsu N; Okayama T; Morikawa A; Mouri T; Tanaka H; Kimura M; Imai H; Mizukami T; Imoto A; Kondoh C; Shiotsu S; Okuyama H; Ueno M; Takahashi T; Tsuji T; Aragane H; Inui A; Higashiguchi T; Takayama K
BMC Cancer; 2019 May; 19(1):528. PubMed ID: 31151425
[TBL] [Abstract][Full Text] [Related]
4. Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Lester J; Parry D; Pettit RJ; Byrne A
BMC Cancer; 2015 Jul; 15():544. PubMed ID: 26204885
[TBL] [Abstract][Full Text] [Related]
5. The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials.
Clarey J; Kao SC; Clarke SJ; Vardy J
Ann Oncol; 2012 May; 23(5):1229-1233. PubMed ID: 21986095
[TBL] [Abstract][Full Text] [Related]
6. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
7. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS).
LeBlanc TW; Samsa GP; Wolf SP; Locke SC; Cella DF; Abernethy AP
Support Care Cancer; 2015 Aug; 23(8):2341-7. PubMed ID: 25586527
[TBL] [Abstract][Full Text] [Related]
8. [Cachexia and Sarcopenia Associated with Lung Cancer].
Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1537-1541. PubMed ID: 33268723
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, risk factors and impact of cachexia on patient outcome: Results from the Japanese Lung Cancer Registry Study.
Shukuya T; Takahashi K; Shintani Y; Miura K; Sekine I; Takayama K; Inoue A; Okamoto I; Kiura K; Kawaguchi T; Yamamoto N; Miyaoka E; Yoshino I; Date H
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1274-1285. PubMed ID: 36905129
[TBL] [Abstract][Full Text] [Related]
10. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
11. Impact of Socioeconomic Status on Pretreatment Weight Loss and Survival in Non-Small-Cell Lung Cancer.
Lau SKM; Gannavarapu BS; Carter K; Gao A; Ahn C; Meyer JJ; Sher DJ; Jatoi A; Infante R; Iyengar P
J Oncol Pract; 2018 Apr; 14(4):e211-e220. PubMed ID: 29558251
[TBL] [Abstract][Full Text] [Related]
12. Cardiac cachexia is associated with right ventricular failure and liver dysfunction.
Valentova M; von Haehling S; Krause C; Ebner N; Steinbeck L; Cramer L; Doehner W; Murin J; Anker SD; Sandek A
Int J Cardiol; 2013 Nov; 169(3):219-24. PubMed ID: 24063924
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive validation of the functional assessment of anorexia/cachexia therapy (FAACT) anorexia/cachexia subscale (A/CS) in lung cancer patients with involuntary weight loss.
Gelhorn HL; Gries KS; Speck RM; Duus EM; Bourne RK; Aggarwal D; Cella D
Qual Life Res; 2019 Jun; 28(6):1641-1653. PubMed ID: 30796591
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.
Zang YS; Fang Z; Li B
Am J Hosp Palliat Care; 2013 Mar; 30(2):210-3. PubMed ID: 23393267
[TBL] [Abstract][Full Text] [Related]
15. Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Slotwiner DJ; Raitt MH; Del-Carpio Munoz F; Mulpuru SK; Nasser N; Peterson PN
Circulation; 2019 Aug; 140(8):e483-e503. PubMed ID: 30586773
[TBL] [Abstract][Full Text] [Related]
16. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
[TBL] [Abstract][Full Text] [Related]
17. Quality of Life in NSCLC Survivors - A Multicenter Cross-Sectional Study.
Hechtner M; Eichler M; Wehler B; Buhl R; Sebastian M; Stratmann J; Schmidberger H; Gohrbandt B; Peuser J; Kortsik C; Nestle U; Wiesemann S; Wirtz H; Wehler T; Bals R; Blettner M; Singer S
J Thorac Oncol; 2019 Mar; 14(3):420-435. PubMed ID: 30508641
[TBL] [Abstract][Full Text] [Related]
18. Association Between 3-Iodothyronamine (T1am) Concentrations and Left Ventricular Function in Chronic Heart Failure.
la Cour JL; Christensen HM; Köhrle J; Lehmphul I; Kistorp C; Nygaard B; Faber J
J Clin Endocrinol Metab; 2019 Apr; 104(4):1232-1238. PubMed ID: 30383216
[TBL] [Abstract][Full Text] [Related]
19. Treatment, outcome and quality of life of 1239 patients with advanced non-small cell lung cancer - final results from the prospective German TLK cohort study.
von Verschuer U; Schnell R; Tessen HW; Eggert J; Binninger A; Spring L; Jänicke M; Marschner N;
Lung Cancer; 2017 Oct; 112():216-224. PubMed ID: 28916198
[TBL] [Abstract][Full Text] [Related]
20. Weight loss over time and survival: a landmark analysis of 1000+ prospectively treated and monitored lung cancer patients.
Le-Rademacher J; Lopez C; Wolfe E; Foster NR; Mandrekar SJ; Wang X; Kumar R; Adjei A; Jatoi A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1501-1508. PubMed ID: 32940014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
